In the current study, we sought to determine whether HIFU ablation could directly increase hypoxia in the residual hepatocellular carcinoma and enhance pro-angiogenic effect through an HIF-1, 2α/VEGFA/EphA2-dependent mechanism. Here, HIF1A is linked to hepatocellular carcinoma.